NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Pallando Therapeutics

Pallando Therapeutics

Private
San Carlos, CaliforniaHealthcare & Life Scienceshttps://pallandotx.com/

Last Round

Seed

Jun 24, 2025

Total Funding Raised

$8M

Company Overview

Pallando Therapeutics is a biotechnology company that provides precision targeting services intended to transform the oncology treatment landscape.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

biotechnologyoncology therapeuticsprecision medicinedrug discoverytargeted protein degradationnext-gen degradersai-augmented drug discoverystealth biotechtherapeutic pipelineprecision targetingbiotech startupr&d partnershipspharma licensingcomputational biology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pallando Therapeutics Comparables

Compare Pallando Therapeutics with similar companies based on industry and business-model similarity.

Pallando Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
TenSixty Bio
81%
Bayer AG
73%
TRIANA Biomedicines
71%

Pallando Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJun 24, 2025

Pallando Therapeutics Investors

Notable investors and investment history

Pallando Therapeutics investors
InvestorRounds
Venture HighwaySeed
BVF Partners L.P.Seed
Astellas Venture ManagementSeed
8VCSeed

Pallando Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Pallando Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Pallando Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Carlos, California
Employee Range7
Year Founded2023
Last FundingJun 24, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.